Novartis AG

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 1.97%37.250.9%$1862.14m
ABBVAbbVie, Inc. 0.67%104.901.9%$1053.65m
JNJJohnson & Johnson 0.38%144.230.7%$1042.81m
BMYBristol-Myers Squibb Co. 0.35%63.061.0%$690.36m
MRKMerck & Co., Inc. -0.21%79.890.7%$680.02m
LLYEli Lilly & Co. 2.00%147.651.1%$659.48m
AZNAstraZeneca Plc 0.02%52.611.2%$313.94m
GSKGlaxoSmithKline Plc -0.42%37.080.2%$225.00m
NVSNovartis AG 0.63%89.740.2%$178.51m
NVONovo Nordisk A/S 2.13%67.550.1%$95.66m
RGENRepligen Corp. 3.07%186.997.1%$94.93m
ARCTArcturus Therapeutics Holdings, Inc. 25.35%76.000.0%$77.61m
SNYSanofi 1.85%51.130.2%$72.29m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.21%91.600.0%$67.14m
RPRXRoyalty Pharma Plc 1.54%41.600.2%$66.73m

Company Profile

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.